Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources

Journal of Nutritional Biochemistry

Volumn 7, Issue 2, 1996, Pages 66-76

  Cook, N C ^a   Samman, S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

chemical structure; coronary heart disease; diet; flavonoids; low density lipoprotein; metabolism; oxidation; platelet aggregation

Indexed keywords

ANTIOXIDANT; APIGENIN; CATECHIN; FLAVONOID; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; LUTEOLIN; MYRICETIN; PROPOLIS; QUERCETIN; SCAVENGER; TANNIN;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; CORONARY ARTERY DISEASE; DIET; DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; FECES; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; MORTALITY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHYTOCHEMISTRY; RAT; REVIEW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; URINE;

EID: 0029867672     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2863(95)00168-9     Document Type: Review

References (84)

1. Middleton, E., Jr. and Kandaswami, C. (1993). The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In The Flavonoids: Advances in Research Since 1986. (J.B. Harborne, ed.), p. 619-652, Chapman and Hall, London, UK
2. Ratty, A.K. and Das, N.P. (1988). Effects of flavonoids on non-enzymic lipid peroxidation: Structure activity relationship. Biochem. Med. Metabol. Biol. 39, 69-79
3. Hackett, A.M. (1986). The metabolism of flavonoid compounds in mammals. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structural-Activity Relationships, p. 177-194, Alan R. Liss, New York, NY USA
4. Hanasaki, Y., Ogawa, S., and Fukui, S. (1994). The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radical Biol. Med. 16, 845-850
5. Hope, W.C., Welton, A.F., Fielder-Nagy, C., Batula-Bernardo, C., and Coffey, J.W. (1983). In vitro inhibition of the biosynthesis of slow reacting substances of anaphylaxis (SRS-A) and lipoxygenase activity of quercetin. Biochem. Pharmacol. 32, 367-371
6. Duarte, J., Vizcaino, F.P., Utrilla, P., Jimenez, J., Tamargo, J., and Zarzuelo, A. (1993). Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure activity relationships. Biochem. Pharmacol. 24, 857-862
7. Salvayre, R., Negre, A., Affany, A., Lenoble, M., and Douste-Blazy, L. (1988). Protective effect of plant flavonoids, analogs and vitamin E against lipid peroxidation of membranes. In Plant Flavonoids in Biology and Medicine II. Biochemical, Cellular and Medicinal Properties, p. 313-316, Alan R. Liss, New York, NY USA
8. Gryglewski, R.J., Korbut, R., Robak, J., and Swies, J. (1987). On the mechanism of antithrombotic action of flavonoids. Biochem. Pharmacol. 36, 317-322
9. Bourdillat, B. Delautier, D., Labat, J., Benveniste, J., Potier, P., and Brink, C. (1988). Mechanism of action of hispidulin, a natural flavone, on human platelets. In Plant Flavonoids in Biology and Medicine II. Biochemical, Cellular and Medicinal Properties, p. 211-214, Alan R. Liss, New York, NY USA
10. Beretz, A. and Cazenave, J. (1988). The effect of flavonoids on blood-vessel wall interactions. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medicinal Properties, p. 187-200, Alan R. Liss, New York, NY USA
11. Beretz, A., Anton, R., and Cazenave, J. (1986). The effect of flavonoids on cyclic nucleotide phosphodiesterase. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, p. 281-296, Alan R. Liss, New York, NY USA
12. Tzeng, S.H., Ko, W.-C., Ko, F.-N. and Teng, C.-M. (1991). Inhibition of platelet aggregation by some flavonoids. Thromb. Res. 64, 91-100
13. Torel, J., Cillard, J., and Cillard, P. (1986). Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry 25, 383-385
14. Budavari, S., O'Neil, M.J., Smith, A., and Heckelman, P.E. (eds.). (1989). The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, 11th ed., Merck & Co., Inc., USA
15. Robak, J., Korbut, R., Shridi, F., Swies, J., and RzadkowskaBodalska, H. (1988). On the mechanism of antiaggregatory effect of myricetin. Pol. J. Pharmacol. Pharm. 40, 337-340
16. Hodnick, W.F., Milosavljevic, E.B., Nelson, J.H., and Pardini, R.S. (1988). Electrochemistry of flavonoids: Relationships between redox potentials, inhibition of mitochondrial respiration and production of oxygen radicals by flavonoids. Biochem. Pharmacol. 37, 2607-2611
17. Pignol, B., Etienne, A., Crastes de Paulet, A., Deby, C., Mencia-Huerta, J.M., and Braquet, P. (1988). Role of flavonoids in the oxygen-free radical modulation of the immune response. In Plant Flavonoids in Biology and Medicine II. Biochemical, Cellular and Medicinal Properties, p. 173-182, Alan R. Liss, New York, NY USA
18. Fraga, C.G., Martino, V.S., Ferraro, G.E., Coussio, J.D., and Boveris, A. (1987). Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol. 36, 717-720
19. Cavallini, L., Bindoli, A., and Siliprandi, N. (1978). Comparative evaluation of antiperoxidative action of silymarin and other flavonoids. Pharmacol. Res. Commun. 10, 133-136
20. Afanas'ev, I.B., Dorozhko, A.I., Brodskii, A.V., Kostyuk, V.A., and Potapovitch, A.I. (1989). Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 38, 1763-1769
21. Yuting, C., Rongliang, Z., Zhongjian, J., and Yong, J. (1990). Flavonoids as superoxide scavengers and antioxidants. Free Radical Biiol. Med. 9, 19-21
22. Mora, A., Paya, M., Rios, J.L., and Alcaraz, M.J. (1990). Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem. Pharmacol. 40, 793-797
23. Rankin, S.M., De Whalley, C.V., Hoult, J.R.S., Jessup, W., Wilkins, G.M., Collard, J., and Leake, D.S. (1993). The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem. Pharmacol. 45, 67-75
24. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L. (1989). Beyond cholesterol: Modification of low-density lipoprotein that increases its atherogenicity. New Engl. J. Med. 320, 915-924
25. Henriksen, T., Mahoney, E.M., and Steinberg, D. (1981). Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cell: Recognition by receptors for acetylated low density lipoprotein. Proc. Natl. Acad. Sci. USA 78, 6499-6507
26. Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E. (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457
27. Renaud, S. and De Lorgeril, M. (1992). Wine, alcohol, platelets, and the French paradox for cononary heart disease. Lancet 339, 1523-1526
28. Rimm, E.B., Giovannucci, E.L., Willet, W.C. Colditz, G.A., Ascherio, A., Rosner, B., and Stampfer, M.J. (1991). Prospective study of alcohol consumption and risk of cononary disease in men. Lancet 338, 464-467
29. Coultate, T.P. (1990). Food: The Chemistry of Its Components, 2nd ed. The Royal Society of Chemistry, p. 137-149
30. Cody, V. (1988). Crystal and molecular structure of flavonoids. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medicinal Properties, p. 29-44, Alan R. Liss, New York, NY USA
31. Harborne, J.B. (1986). Nature, distribution and function of plant flavonoids. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships, p. 15-24, Alan R. Liss, New York, NY USA
32. Harborne, J.B. (1988). Flavonoids in the environment: Structure-activity relationships. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medicinal Properties, p. 17-27, Alan R. Liss, New York, NY USA
33. Kühnau, J. (1976). The Flavonoids. A class of semi-essential food components: Their role in human nutrition. Wld. Rev. Nutr. Diet. 24, 117-191
34. Havsteen, B. (1983). Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32, 1141-1148
35. Hertog, M.G.L., Hollman, P.C.H., Katan, M.B., and Kromhout, D. (1993). Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer 20, 21-29
36. Brune, M., Rossander, L., and Hallberg, L. (1989). Iron absorption and phenolic compound: Importance of different phenolic structures. Eur. J. Clin. Nutr. 43, 547-558
37. Pierpoint, W.S. (1986). Flavonoids in the human diet. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, p. 125-140, Alan R. Liss, New York, NY USA
38. Muramatsu, K., Fukuyo, M., and Hara, Y. (1986). Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 32, 613-622
39. Swain, T. (1986). The evolution of flavonoids. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships, p. 1-14, Alan R. Liss, New York, NY USA
40. Bravo, L., Abia, R., Eastwood, M.A., and Saura-Calixto, F. (1994). Degradation of polyphenols (catechin and tannic acid) in the rat intestinal tract. Effect on colonic fermentation and faecal output. Brit. J. Nutr. 71, 933-946
41. De Whalley, C.V., Rankin, S.M., Hoult, J.R.S., Jessup, W., and Leake, D.S. (1990). Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol. 39, 1743-1750
42. Das, N.P. (1971). Studies on flavonoid metabolism: Absorption and metabolism of (+)-catechin in Man. Biochem. Pharmacol. 20, 3435-3445
43. Gugler, R., Leschik, M., and Dengler, H.J. (1975). Disposition of quercetin in Man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 9, 229-234
44. Kaul, N., Siveski-Iliskovic, N., Hill, M., Slezak, J., and Singal, P.K. (1993). Free radicals and the heart. J. Pharmacol. Toxicol. Meth. 30, 55-67
45. Niki, E. (1987). Antioxidants in relation to lipid peroxidation. Chem. Phys. Lipids 44, 227-253
46. Robak, J. and Gryglewski, R.J. (1988). Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37, 837-841
47. Das, N.P. and Ratty, A.K. (1986). Effect of flavonoids on induced non-enzymic lipid peroxidation. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships, p. 243-247, Alan R. Liss, New York, NY USA
48. Morel, I., Lescoat, G., Cogrel, P., Sergent, O., Pasdeloup, N., Brissot, P., Cillard, P. and Cillard, J. (1993). Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13-19
49. 4-induced microsomal lipid peroxidation. Experientia 47, 195-199
50. Husain, S.R., Cillard, J., and Cillard, P. (1987). Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26, 2489-2491
51. Bokkenheuser, V.D. and Winter, J. (1988). Hydrolysis of flavonoids by human bacteria. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medical Properties, p. 143-145, Alan R. Liss, New York, NY USA
52. Goldstein, J.L. and Brown, M.S. (1983). Lipid metabolism in the macrophage. Ann. Rev. Biochem. 52, 223-262
53. Goldstein, J.L., Ho, Y.K., Basu, S.K., and Brown, M.S. (1979). Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76, 333-337
54. Sparrow, C.P., Parthasarathy, S., and Steinberg, D. (1989). A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264, 2599-2604
55. Kodama, T., Freeman, M., Rohrer, L., Zadrecky, J., Matsudaira, P., and Krieger, M. (1990). Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343, 531-535
56. Jurgens, G., Hoff, H.F., Chisolm, G.M., and Esterbauer, H. (1987). Modification of human serum low density lipoprotein by oxidation. Characterization and pathophysiological implications. Chem. Phys. Lipids. 45, 315-336
57. Mangiapane, H., Thomson, J., Salter, A., Brown, S., Bell, G.D., and White, D.A. (1992). The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. Biochem. Pharmacol. 43, 445-450
58. Palinsky, W., Rosenfeld, M.E., Yla-Herttula, S., Grutner, G.C., Socher, S.S., Butler, S.W., Parthasarathy, S., Carew, T.E., Steinberg, D., and Witzum, J.L. (1989). Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86, 1372-1376
59. Jessup, W., Rankin, S.M., de Whalley, C.V., Hoult, J.R.S., Scott, J., and Leake, D.S. (1990). Tocopherol consumption during LDL oxidation. Biochem. J. 265, 399-405
60. Stocker, R. (1993). Natural antioxidants and atherosclerosis. Asia Pac. J. Clin. Nutr. 2 (Suppl 1), 15-20
61. Frei, B. and Gaziano, J.M. (1993). Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and independent oxidation. J. Lipid Res. 34, 2135-2145
62. Steinbrecher, U.P., Parthasarathy, S., Leake, D.S., and Witztum, J.L. (1984). Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81, 3883-3887
63. Negre-Salvayre, A. and Salvayre, R. (1992). Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radical Biol. Med. 12, 101-106
64. Parthasarathy, S., Young, S.G., Witztum, J.L., Pittman, R.C., and Steinberg, D. (1986). Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77, 641-644
65. Negre-Salvayre, A., Alomar, Y., Troly, M., and Salvayre, R. (1991). Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim. Biophys. Acta. 1096, 291-300
66. Gaziano, J.M. and Hennekens, C.H. (1993). The epidemiology of dietary antioxidants and atherosclerotic disease. Asia Pac. J. Clin. Nutr. 2, (Suppl 1), 27-31
67. Bellizzi, M.C., Franklin, M.F., Duthie, G.G., and James, W.P.T. (1994). Vitamin E and coronary heart disease: the European paradox. Eur. J. Clin. Nutr. 48, 822-831
68. Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., and Kromhout, D. (1993). Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342, 1007-1011
69. Hertog, M.G.L., Hollman, P.C.H., and Van de Putte, B. (1993). Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J. Agric. Food Chem. 41, 1242-1246
70. Hertog, M.G.L., Hollman, P.C.H., and Katan, M.B. (1992). Content of potentially anticarcinogenic flavonoid of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J. Agric. Food Chem. 40, 2379-2383
71. Fuhrman, B., Lavy, A., and Aviram, M. (1995). Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to lipid peroxidation. Am. J. Clin. Nutr. 61, 549-554
72. Whitehead, T.P., Robinson, D., Allaway, S., Syms, J., and Hale, A. (1995). Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 41, 32-35
73. Beretz, A., Cazenave, J.-P., and Anton, A. (1982). Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationships. Agent. Actio. 12, 382-387
74. Swies, J., Robak, J., Dabrowski, L., Duniec, Z., Michalska, Z., and Gryglewski, R.J. (1984). Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro. Pol. J. Pharmacol. Pharm. 36, 455-463
75. Elliott, A.J., Scheiber, S.A., Thomas, C., and Pardini, R.S. (1992). Inhibition of glutathione reductase by flavonoids. A structure-activity study. Biochem. Pharmacol. 44, 1603-1608
76. Landolfi, R., Mower, R.L., and Steiner, M. (1984). Modification of platelet function and arachidonic acid metabolism by bioflavonoids: Structure-activity relations. Biochem. Pharmacol. 33, 1525-1530
77. Ferrell, J.E., Chang Sing, P.D.G., Loew, G., King, R., Mansour, J.M., and Mansour, T.E. (1979). Structure-activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum indices. Mol. Pharmacol. 16, 556-568
78. Kuppusamy, U.R. and Das, N.P. (1992). Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem. Pharmacol. 44, 1307-1315
79. Ruf, J.-C., Berger, J.-L., and Renaud, S. (1995). Platelet rebound effect of alcohol withdrawal and wine drinking in rats: Relation to tannins and lipid peroxidation. Atherioscler. Thromb. Vasc. Biol. 15, 140-144
80. Criqui, M.H. and Ringel, B.L. (1994). Does diet or alcohol explain the French paradox? Lancet 344, 1719-1723
81. Hertog, M.G.L., Hollman, P.C.H., and Venema, D.P. (1992). Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J. Agric. Food Chem. 40, 1591-1598
82. Jaeger, A., Walti, M., and Neftel, K. (1988). Side effects of flavonoids in medical practice. In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medical Properties, p. 379-394, Alan R. Liss, New York, NY USA
83. Goldberg, D.M. (1995). Does wine work? Clin. Chem. 41, 14-16
84. Hirono, I., Ueno, I., Hosaka, S., Takanashi, H., Matsushima, T., Sugimura, T., and Natori, S. (1981). Carcinogenicity examination of quercetin and rutin in ACl rats. Cancer Lett. 13, 15-21